EU-END_OF_LIFE_VEHICLES-ART_2_11

EU-END_OF_LIFE_VEHICLES-ART_2_11

End-of-Life Vehicles Directive - Hazardous Substances

EU. Hazardous Substances per Article 2(11) of End-of-Life Vehicles Directive 2000/53/EC, 21 October 2000, amended by Directive 2020/363/EU, 5 March 2020 (based on Table 3/Annex VI of CLP)

This list contains a non-exhaustive inventory of hazardous substances as defined by Article 2(11) of the End-of-Life Vehicles Directive 2000/53/EC. It is based on the relevant subset of substances with harmonised classification listed in Table 3 of Annex VI to the CLP Regulation 1272/2008/EC.

Last updated 23 April 2024. Database contains 4356 unique substances/entries.

Filter the list

Showing 101 - 150 of 4,356 results.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)
3-azidosulfonylbenzoic acid ASB	405-310-3	15980-11-7	STOT RE 2
2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazoly]methyl]amino]carbonyl}-L-Valinate	424-660-8	-	STOT RE 2
((4-phenylbutyl)hydroxyphosphoryl)acetic acid SQ 26999	412-170-7	83623-61-4	STOT RE 2
solvent naphtha (petroleum), medium aliph.; Straight run kerosine [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140°C to 220°C (284°F to 428°F).] A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140°C to 220°C (284°F to 428°F).	265-191-7	64742-88-7	STOT RE 1; Asp. Tox. 1
trioctylstannane TZ 02508	413-320-4	869-59-0	STOT RE 1; Aquatic Chronic 4
reaction mass of: butan-2-one oxime; syn-O,O'-di(butan-2-one oxime)diethoxysilane DOW CORNING (R) 4-2920 INTERMEDIATE	406-930-7	96-29-7	STOT RE 1; Aquatic Chronic 3
reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate; 2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1) RED E190	411-560-4	-	STOT RE 1; Aquatic Chronic 2
4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride WL 125892	402-190-4	113674-95-6	STOT RE 1; Acute Tox. 4; STOT RE 2; Aquatic Acute 1; Aquatic Chronic 1
N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide	423-530-8	152828-23-4	STOT RE 1; Acute Tox. 4; Aquatic Chronic 3
(1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride	426-200-1	172015-79-1	STOT RE 1; Acute Tox. 4; Aquatic Chronic 3
trisodium hexafluoroaluminate(cryolite)	239-148-8	15096-52-3	STOT RE 1; Acute Tox. 4; Aquatic Chronic 2
trisodium hexafluoroaluminate	237-410-6	13775-53-6	STOT RE 1; Acute Tox. 4; Aquatic Chronic 2
dicoumarol; 4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one)	200-632-9	66-76-2	STOT RE 1; Acute Tox. 4; Aquatic Chronic 2
dibenzylphenylsulfonium hexafluoroantimonate ZK RT 1507	417-760-8	134164-24-2	STOT RE 1; Acute Tox. 4; Aquatic Chronic 2
2-nitro-2-phenyl-1,3-propanediol 2-NPP	410-360-4	5428-02-4	STOT RE 1; Acute Tox. 4; Aquatic Chronic 2
tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate	428-070-1	91788-83-9	STOT RE 1; Acute Tox. 4; Aquatic Acute 1; Aquatic Chronic 1
reaction mass of: tri-p-tolyltin hydroxide; hexa-p-tolyl-distannoxane	432-230-6	-	STOT RE 1; Acute Tox. 4; Aquatic Acute 1; Aquatic Chronic 1
5,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone HYDRAMETHYLNON	405-090-9	67485-29-4	STOT RE 1; Acute Tox. 4; Aquatic Acute 1; Aquatic Chronic 1
1-aminocyclopentanecarboxamide	422-950-9	17193-28-1	STOT RE 1; Acute Tox. 4
benzoic acid	200-618-2	65-85-0	STOT RE 1
triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate	432-270-4	221354-37-6	Repr. 2; STOT RE 2; Aquatic Chronic 2
amitrole (ISO);1,2,4-triazol-3-ylamine	200-521-5	61-82-5	Repr. 2; STOT RE 2; Aquatic Chronic 2
2-(4-tert-butylphenyl)ethanol TBPE	410-020-5	5406-86-0	Repr. 2; STOT RE 2; Aquatic Chronic 2
dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin- 4-ium acetate	250-778-2	31717-87-0	Repr. 2; STOT RE 2; Aquatic Chronic 1
triticonazole (ISO); (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol	-	138182-18-0	Repr. 2; STOT RE 2; Aquatic Acute 1; Aquatic Chronic 1
tembotrione (ISO); 2-{2- chloro-4-(methylsulfonyl)-3- [(2,2,2-trifluoroethoxy)methyl] benzoyl}cyclohexane-1,3-dione	608-879-8	335104-84-2	Repr. 2; STOT RE 2; Aquatic Acute 1; Aquatic Chronic 1
sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione	619-394-6	99105-77-8	Repr. 2; STOT RE 2; Aquatic Acute 1; Aquatic Chronic 1
oxadiargyl (ISO); 3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one	254-637-6	39807-15-3	Repr. 2; STOT RE 2; Aquatic Acute 1; Aquatic Chronic 1
mesotrione(ISO); 2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione	600-533-4	104206-82-8	Repr. 2; STOT RE 2; Aquatic Acute 1; Aquatic Chronic 1
dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine	216-474-9	1593-77-7	Repr. 2; STOT RE 2; Aquatic Acute 1; Aquatic Chronic 1
metaflumizone (ISO); (EZ)-2-[2-(4-cyanophe-nyl)-1-(a,a,a -trifluoro-m-tolyl)ethylidene]-[4-(tri-fluoromethoxy)phenyl] carbanilohydrazide [E-iso-mer > 90 %, Z-isomer <10 % relative content]	604-167-6	139968-49-3	Repr. 2; STOT RE 2
metaflumizone (ISO); (E)-2-[2-(4-cyanophenyl)-1-(a,a,a -trifluoro-m-tolyl) ethylidene]-[4-(trifluoro-methoxy)phenyl]carbani-lohydrazide [2]	701-454-9	852403-68-0	Repr. 2; STOT RE 2
(S)-2,3-dihydro-1H-indole-2-carboxylic acid [S]-2-INDOLINE CARBOXYLIC ACID	410-860-2	79815-20-6	Repr. 2; STOT RE 2
(R, S)-2-amino-3,3-dimethylbutane amide	447-860-7	144177-62-8	Repr. 2; STOT RE 2
(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole UK-111,975	422-390-5	143322-57-0	Repr. 2; STOT RE 1; Acute Tox. 4; Aquatic Acute 1; Aquatic Chronic 1
N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide QUESTAMIDE H	422-560-9	149591-38-8	Repr. 2; Aquatic Chronic 4
3-oxoandrost-4-ene-17-β-carboxylic acid CC14837; SKF 106224	414-990-0	302-97-6	Repr. 2; Aquatic Chronic 4
piperazine phosphate	217-775-8	1951-97-9	Repr. 2; Aquatic Chronic 3
piperazine hydrochloride	228-042-7	6094-40-2	Repr. 2; Aquatic Chronic 3
piperazine dihydrochloride	205-551-2	142-64-3	Repr. 2; Aquatic Chronic 3
1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid CHINOLONCARBONSÄURE 93-073; CP-70,335	413-760-7	93107-30-3	Repr. 2; Aquatic Chronic 3
fenarimol (ISO); 2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol	262-095-7	60168-88-9	Repr. 2; Aquatic Chronic 2
4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol	428-970-4	13595-25-0	Repr. 2; Aquatic Chronic 2
2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropyl formate SCARLET PE 3948	424-260-3	784157-49-9	Repr. 2; Aquatic Chronic 2
(R)-α-phenylethylammonium(-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate PHENETHYLAMMONIUM SALT OF FOSFOMYCIN	418-570-8	25383-07-7	Repr. 2; Aquatic Chronic 2
octamethylcyclotetrasiloxane; [D4]	209-136-7	556-67-2	Repr. 2; Aquatic Chronic 1
Margosa, ext. [cold-pressed oil of Azadirachta indica seeds without shells extracted with super-critical carbon dioxide];Margosa, ext. [from the kernels of Azadirachta indica extracted with water and further processed with organic solvents] Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Azadirachta indica, Meliaceae.	283-644-7	84696-25-3	Repr. 2; Aquatic Chronic 1
4-tert-butylphenol	202-679-0	98-54-4	Repr. 2; Aquatic Chronic 1
spirotetramat (ISO); (5s,8s)-3- (2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec- 3-en-4-yl ethyl carbonate	606-523-6	203313-25-1	Repr. 2; Aquatic Acute 1; Aquatic Chronic 1
silver zinc zeolite (Zeolite, LTA framework type, surface-modified with silver and zinc ions)	603-404-0	130328-20-0	Repr. 2; Aquatic Acute 1; Aquatic Chronic 1

Showing 101 - 150 of 4,356 results.

Export search results to: